All Stories

  1. ASRI Guidelines on Recurrent Pregnancy Loss: Addressing Concerns and Reinforcing Evidence‐Based, Specialized Care
  2. Reproductive Immunology: Current Knowledge and New Perspectives
  3. Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss
  4. 2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship
  5. Effects of physical activity in women with polycystic ovary syndrome: a systematic review and meta-analysis
  6. Endometriosis and Infertility: A Bibliometric Analysis of the 100 Most-Cited Articles from 2000 to 2023
  7. Repeated ovarian hyperstimulation promotes depression-like behavior in female mice
  8. Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: Systematic review and meta-analysis
  9. Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure
  10. Obesity and recurrent miscarriage: The interconnections between adipose tissue and the immune system
  11. ESHRE guideline update 2022: New perspectives in the management of couples with recurrent pregnancy loss
  12. Self-made transvaginal ultrasound simulator: new training equipment in ultrasound evaluation of controlled ovarian stimulation and oocyte retrieval
  13. Kisspeptin as a predictor of miscarriage: a systematic review
  14. Ovarian aging in humans: potential strategies for extending reproductive lifespan
  15. Screening for coronavirus disease 2019 in pregnant women admitted for delivery: an observational study
  16. The Dietary Inflammatory Index as a predictor of pregnancy outcomes: Systematic review and meta-analysis
  17. Extracorporeal membrane oxygenation support in children with severe coronavirus disease-2019: A case series
  18. Recurrent pregnancy loss and hereditary thrombophilias – is it time to review the guidelines?
  19. Immunotherapies to optimize pregnancy outcomes in subfertile women
  20. Plasma miRNA Profile of Crohn’s Disease and Rheumatoid Arthritis Patients
  21. Unexplained recurrent miscarriages: Predictive value of immune biomarkers and immunomodulatory therapies for live birth
  22. COVID-19 and miscarriage: From immunopathological mechanisms to actual clinical evidence
  23. Baseline endothelial-related biomarkers in hemodialysis patients and risk of developing severe SARS-Cov-2 infection
  24. Evaluation of paternal lymphocyte immunotherapy and potential biomarker mixed lymphocyte reaction‐blocking factor in an Argentinian cohort of women with unexplained recurrent spontaneous abortion and unexplained infertility
  25. Biomarkers of acute kidney injury in pediatric cardiac surgery
  26. Specific PIWI-Interacting RNAs and Related Small Noncoding RNAs Are Associated With Ovarian Aging in Ames Dwarf (df/df) Mice
  27. Endometrial scratching for embryo implantation failure—uterine immune biomarkers as a selection criterion
  28. Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure
  29. Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring
  30. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice
  31. COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding
  32. Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
  33. The Interconnections Between Somatic and Ovarian Aging in Murine Models
  34. COVID-19 and immunomodulation treatment for women with reproductive failures
  35. Is there any possible link between COVID-19 and human infertility?
  36. Letter: COVID-19 and human reproduction: hypothesis needs to be investigated
  37. Intrauterine perfusion immunotherapies in recurrent implantation failures: Systematic review
  38. Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice
  39. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta‐analysis
  40. Dasatinib Plus Quercetin on Uterine Age-Related Dysfunction and Fibrosis in Mice
  41. Recombinant human granulocyte–colony stimulating factor for all recurrent miscarriage patients or for a select group?
  42. The enigmatic role of growth hormone in age-related diseases, cognition, and longevity
  43. Coagulation Biomarkers in Women with Recurrent Miscarriage and Polycystic Ovarian Syndrome: Systematic Review and Meta-Analysis
  44. Gestational and perinatal outcomes in recurrent miscarriages couples treated with lymphocyte immunotherapy
  45. Perinatal unusual rhabdomyoma location – case report and systematic reviews of the literature
  46. Obesity increases the risk of miscarriage in patients with recurrent miscarriages.
  47. Cytogenetic and recurrent miscarriages.
  48. Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success
  49. Early treatment of intrapericardial teratoma: a case presentation and systematic literature review
  50. Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis
  51. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy
  52. Autoimmunity and thrombophilia in women treated with lymphocyte immunotherapy
  53. Etiological factors associated with alloimmunity in women with recurrent miscarriage
  54. Gastric contractility in experimental gastroschisis
  55. Interferência da idade sobre a qualidade seminal
  56. Criopreservação de sêmen humano: comparação entre métodos de congelação e tipos de envase
  57. Risk factors for death and changing patterns in leptospirosis acute renal failure.